S. Ge´rard, J. Marchand-Brynaert / Tetrahedron Letters 44 (2003) 6339–6342
6341
sponding mesylate.1 Our contribution has now defined
better the scope and limitation of the reactivity of
1-t-butyldimethylsilyl-4-hydroxymethyl-2-azetidinone, a
key intermediate for antibiotic synthesis.
(CH2O), 128.4 129.5 and 129.6 (CHAr), 133.1 (CAr), 166.1
and 171.8 (2×CꢀO); m/z (EI) 319 (3), 121 (69), 105 (100)
and 77 (66).
12. Synthesis and characterization of 1-phenethyloxycar-
bonyl-4-benzoyloxymethyl-2-azetidinone (3). A solution
of 2 (169 mg; 0.5 mmol) and cesium fluoride (114 mg;
0.75 mmol) in dry DMF (3 mL) was stirred for 2 h at
room temperature. The crude mixture was concentrated
and after addition of EtOAc, the organic layer was
washed twice with water, dried over MgSO4, filtered and
concentrated under vacuum. A solution of the depro-
tected b-lactam in THF (5 mL), cooled at −78°C under
argon atmosphere, was dropwise added to a solution of
LiHMDS (1 equiv.) in dry THF (3 mL). The mixture was
stirred for 30 min at −78°C, then phenethyl chlorofor-
mate (46 mg; 0.25 mmol) was added with a syringe
through a rubber stopper. Stirring was continued for 1 h
at this temperature and the mixture was allowed to reach
room temperature and stirred for 3 h at 20°C. After
addition of 10% NH4Cl (10 mL) and extraction with
CH2Cl2, the organic layer was dried over MgSO4, filtered
and concentrated under vacuum. The resulting b-lactam
was purified by column chromatography on silica gel
(CH2Cl2:EtOAc, 90/10) to yield 3 (33 mg, 38%) as a
colorless oil; (Found HRMS: 354.1341. C20H20NO5
requires 354.1341); wmax/cm−1 1817 and 1726; lH (500
MHz; CDCl3; Me4Si) 3.00 (2H, t, J 7.3, CH2CH2Ph),
3.05 (1H, dd, J 16.0 and 6.2, H-3), 3.19 (1H, dd, J 16.0
and 3.5, H-3%), 4.33 (1H, m, H-4), 4.43 (2H, t, J 7.3,
CH2CH2Ph), 4.56 (1H, dd, J 12.1 and 3.8, CH2O), 4.69
(1H, dd, J 12.1 and 3.1, CH2O), 7.15–7.69 (8H, m, Ar),
8.01–8.05 (2H, m, Ar); lC (100 MHz; CDCl3; Me4Si) 34.9
(CH2CH2Ph), 39.6 (C-3), 49.4 (C-4), 61.2 (CH2O), 67.0
(CH2CH2Ph), 126.7 128.4 129.2 129.5 and 129.6 (CHAr),
133.3 and 136.8 (CAr), 148.7 (CO carbamate), 163.1 and
165.9 (CO azetidinone and CO amide); m/z (CI) 354
(M+1, 4), 105 (100), 91 (12) and 77 (66).
13. Synthesis and characterization of 1-benzyl-4-(2%,4%-dioxa-
3%-oxy-6%-phenylhexyl)-2-azetidinone (5). A solution of
nBuLi (600 mL; 2M in hexane; 1.2 mmol) was added to a
solution of 1 (216 mg; 1 mmol) in dry THF (10 mL),
cooled at −78°C under argon atmosphere. Benzyl bro-
mide (130 mL; 1.1 mmol) was added dropwise and the
mixture was stirred for 3 h at −78°C. The solution was
then washed with water (10 mL), dried over MgSO4,
filtered and concentrated under vacuum. A solution of
the resulting b-lactam 4 (169 mg; 0.5 mmol) and cesium
fluoride (114 mg; 0.75 mmol) in dry DMF (3 mL) was
stirred for 2 h at room temperature. The crude mixture
was concentrated and after addition of EtOAc, the
organic layer was washed twice with water, dried over
MgSO4, filtered and concentrated under vacuum. A solu-
tion of the deprotected b-lactam in THF (5 mL), cooled
at −78°C under argon atmosphere, was added dropwise
to a solution of LiHMDS (1 equiv.) in dry THF (5 mL).
The mixture was stirred for 30 min at −78°C, then
phenethyl chloroformate (46 mg; 0.25 mmol) was added
with a syringe through a rubber stopper. Stirring was
continued for 30 min at this temperature and the mixture
was allowed to reach room temperature and stirred for 3
h at 20°C. After addition of 10% NH4Cl (5 mL) and
extraction with CH2Cl2, the organic layer was dried over
MgSO4, filtered and concentrated under vacuum. The
Acknowledgements
This work was supported by UCL (Universite´
catholique de Louvain), FNRS (Fonds National de la
Recherche Scientifique) and PAI (Poˆle d’Attraction
Inter-universitaire). J. M.-B. is senior research associate
of FNRS.
References
1. McCombie, S. W.; Metz, W. A.; Afonso, A. Tetrahedron
Lett. 1986, 305–308.
2. Banfi, L.; Cascio, G.; Ghiron, C.; Guanti, G.; Manghisi,
E.; Narisano, E.; Riva, R. Tetrahedron 1994, 50, 11983–
11994.
3. Banfi, L.; Basso, A.; Guanti, G. Tetrahedron 1997, 53,
3249–3268.
4. Cundy, D. J.; Donohue, A. C.; McCarthy, T. D. J.
Chem. Soc., Perkin Trans. 1 1999, 559–567.
5. Kende, A. S.; Liu, K.; Kaldor, I.; Dorey, G.; Koch, K. J.
Am. Chem. Soc. 1995, 117, 8258–8270.
6. Ge´rard, S.; Nollet, G.; Vande Put, J.; Marchand-Bry-
naert, J. Bioorg. Med. Chem. 2002, 10, 3955–3964.
7. Ge´rard, S.; Dive, G.; Clamot, B.; Touillaux, R.;
Marchand-Brynaert, J. Tetrahedron 2002, 58, 2423–2433.
8. Salzmann, T. N.; Ratcliffe, R. W.; Christensen, B. G.;
Bouffard, F. A. J. Am. Chem. Soc. 1980, 102, 6161–6163.
9. Baldwin, J. E.; Adlington, R. M.; Collins, D. W.;
Schofield, C. J. Tetrahedron 1990, 46, 4733–4748.
10. Adlington, R. M.; Baldwin, J. E.; Becker, G. W.; Chen,
B.; Cheng, L.; Cooper, S. L.; Hermann, R. B.; Howe, T.
J.; McCoull, W.; McNulty, A. M.; Neubauer, B. L.;
Pritchard, G. J. J. Med. Chem. 2001, 44, 1491–1508.
11. Synthesis and characterization of 4-benzoyloxymethyl-N-
(tert-butyldimethylsilyl)-2-azetidinone (2). A solution of 1
(216 mg; 1 mmol) and DMAP (catalytic amount) in dry
CH2Cl2 (10 mL) was stirred at room temperature. Tri-
ethylamine (140 mL; 1 mmol) and benzoyl chloride (120
mL; 1 mmol) were added and stirring was continued for
20 h. Then, excess of triethylamine (28 mL; 0.2 mmol) and
benzoyl chloride (23 mL; 0.2 mmol) were added to the
solution and the mixture was stirred for an additional 20
h. The solution was washed three times with water (10
mL) and dried over MgSO4. After filtration and concen-
tration under vacuum, the resulting b-lactam was purified
by column chromatography on silica gel (CH2Cl2) to
yield 2 (261 mg, 82%) as a colorless oil. (Found: C, 63.96;
H, 7.87; N, 4.38%. C17H25O3NSi requires C, 63.91; H,
7.89; N, 4.38%); wmax/cm−1 1791, 1718 and 1180; dH (300
MHz; CDCl3; Me4Si) 0.27 (6H, s, 2×SiCH3), 0.95 (9H, s,
C(CH3)3), 2.98 (1H, dd, J 15.9 and 6.3, H-3), 3.25 (1H,
dd, J 15.9 and 3.4, H-3%), 3.95 (1H, m, H-4), 4.38 (1H, dd,
J 11.1 and 2.5, CH2O), 4.52 (1H, dd, J 11.1 and 2.4,
CH2O), 7.45–7.54 (3H, m, Ar), 8.01–8.09 (2H, m, Ar); lC
(75 MHz; CDCl3; Me4Si) −5.6 and −5.5 (SiCH3), 18.0
(C(CH3)3), 26.1 (C(CH3)3), 41.7 (C-4), 47.3 (C-3), 65.9